These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37125560)

  • 21. Magnetic resonance imaging of the cervical spinal cord in spinal muscular atrophy.
    Stam M; Haakma W; Kuster L; Froeling M; Philippens MEP; Bos C; Leemans A; Otto LAM; van den Berg LH; Hendrikse J; van der Pol WL
    Neuroimage Clin; 2019; 24():102002. PubMed ID: 31622841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical spectrum and diagnostic criteria of infantile spinal muscular atrophy: further delineation on the basis of SMN gene deletion findings.
    Rudnik-Schöneborn S; Forkert R; Hahnen E; Wirth B; Zerres K
    Neuropediatrics; 1996 Feb; 27(1):8-15. PubMed ID: 8677029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance reveals mitochondrial dysfunction and muscle remodelling in spinal muscular atrophy.
    Habets LE; Bartels B; Asselman FL; Hooijmans MT; van den Berg S; Nederveen AJ; van der Pol WL; Jeneson JAL
    Brain; 2022 May; 145(4):1422-1435. PubMed ID: 34788410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 - A Prospective Observational Study.
    Walter MC; Wenninger S; Thiele S; Stauber J; Hiebeler M; Greckl E; Stahl K; Pechmann A; Lochmüller H; Kirschner J; Schoser B
    J Neuromuscul Dis; 2019; 6(4):453-465. PubMed ID: 31594243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy.
    Pechmann A; Behrens M; Dörnbrack K; Tassoni A; Stein S; Vogt S; Zöller D; Bernert G; Hagenacker T; Schara-Schmidt U; Schwersenz I; Walter MC; Baumann M; Baumgartner M; Deschauer M; Eisenkölbl A; Flotats-Bastardas M; Hahn A; Horber V; Husain RA; Illsinger S; Johannsen J; Köhler C; Kölbel H; Müller M; von Moers A; Schlachter K; Schreiber G; Schwartz O; Smitka M; Steiner E; Stögmann E; Trollmann R; Vill K; Weiß C; Wiegand G; Ziegler A; Lochmüller H; Kirschner J;
    Brain; 2023 Feb; 146(2):668-677. PubMed ID: 35857854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals.
    Hahnen E; Forkert R; Marke C; Rudnik-Schöneborn S; Schönling J; Zerres K; Wirth B
    Hum Mol Genet; 1995 Oct; 4(10):1927-33. PubMed ID: 8595417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.
    Glascock J; Sampson J; Haidet-Phillips A; Connolly A; Darras B; Day J; Finkel R; Howell RR; Klinger K; Kuntz N; Prior T; Shieh PB; Crawford TO; Kerr D; Jarecki J
    J Neuromuscul Dis; 2018; 5(2):145-158. PubMed ID: 29614695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years.
    Vill K; Schwartz O; Blaschek A; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Czibere L; Durner J; Eggermann K; Olgemöller B; Harms E; Schara U; Kölbel H; Müller-Felber W
    Orphanet J Rare Dis; 2021 Mar; 16(1):153. PubMed ID: 33789695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
    Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
    J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling.
    Finegan E; Li Hi Shing S; Chipika RH; Doherty MA; Hengeveld JC; Vajda A; Donaghy C; Pender N; McLaughlin RL; Hardiman O; Bede P
    Neuroimage Clin; 2019; 24():102089. PubMed ID: 31795059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.
    Wadman RI; Wijngaarde CA; Stam M; Bartels B; Otto LAM; Lemmink HH; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    Eur J Neurol; 2018 Mar; 25(3):512-518. PubMed ID: 29194869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis.
    Gauthier-Loiselle M; Cloutier M; Toro W; Patel A; Shi S; Davidson M; Bischof M; LaMarca N; Dabbous O
    Adv Ther; 2021 Dec; 38(12):5809-5828. PubMed ID: 34713391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study.
    Kariyawasam DS; D'Silva AM; Sampaio H; Briggs N; Herbert K; Wiley V; Farrar MA
    Lancet Child Adolesc Health; 2023 Mar; 7(3):159-170. PubMed ID: 36669516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted sequencing with expanded gene profile enables high diagnostic yield in non-5q-spinal muscular atrophies.
    Karakaya M; Storbeck M; Strathmann EA; Delle Vedove A; Hölker I; Altmueller J; Naghiyeva L; Schmitz-Steinkrüger L; Vezyroglou K; Motameny S; Alawbathani S; Thiele H; Polat AI; Okur D; Boostani R; Karimiani EG; Wunderlich G; Ardicli D; Topaloglu H; Kirschner J; Schrank B; Maroofian R; Magnusson O; Yis U; Nürnberg P; Heller R; Wirth B
    Hum Mutat; 2018 Sep; 39(9):1284-1298. PubMed ID: 29858556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spinal muscular atrophy: MR evaluation.
    Liu GC; Jong YJ; Chiang CH; Yang CW
    Pediatr Radiol; 1992; 22(8):584-6. PubMed ID: 1491935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bulbar muscle MRI changes in patients with SMA with reduced mouth opening and dysphagia.
    Wadman RI; van Bruggen HW; Witkamp TD; Sparreboom-Kalaykova SI; Stam M; van den Berg LH; Steenks MH; van der Pol WL
    Neurology; 2014 Sep; 83(12):1060-6. PubMed ID: 25122201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and radiological profile of patients with spinal muscular atrophy type 4.
    Souza PVS; Pinto WBVR; Ricarte A; Badia BML; Seneor DD; Teixeira DT; Caetano L; Gonçalves EA; Chieia MAT; Farias IB; Bertini E; Oliveira ASB
    Eur J Neurol; 2021 Feb; 28(2):609-619. PubMed ID: 33090613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Infantile spinal muscular atrophy : therapeutic (R)evolution].
    Daron A; Delstanche S; Dangouloff T; Servais L
    Rev Med Liege; 2019 Feb; 74(2):82-85. PubMed ID: 30793560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spinal Muscular Atrophy: Autopsy Based Neuropathological Demonstration.
    Thirunavukkarasu B; Gupta K; Bansal A; Dhanasekaran N; Baranwal A
    Neurol India; 2020; 68(4):882-885. PubMed ID: 32859833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nusinersen treatment of Spinal Muscular Atrophy Type 1 - results of expanded access programme in Poland.
    Modrzejewska S; Kotulska K; Kopyta I; Grędowska E; Emich-Widera E; Tomaszek K; Paprocka J; Chmielewski D; Pilch J; Pietruszewski J; Lemska A; Zawadzka M; Mazurkiewicz-Bełdzińska M
    Neurol Neurochir Pol; 2021; 55(3):289-294. PubMed ID: 33565602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.